Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Difficult asthma in children.

S A McKenzie1, A Bush

  • 1Department of Paediatrics, Royal London Hospital, UK. S.A.McKenzie@qmul.ac.uk

Thorax
|September 27, 2002
PubMed
Summary
This summary is machine-generated.

Asthmatic children on high-dose corticosteroids require thorough assessment to confirm treatment necessity. Future research should address adherence issues and explore new treatments for difficult asthma cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subthalamic nucleus neurons encode syllable sequence and phonetic characteristics during speech.

Journal of neurophysiology·2024
Same author

The new biologic drugs: Which children with asthma should get what?

Pediatric pulmonology·2024
Same author

Replicate DNA metabarcoding can discriminate seasonal and spatial abundance shifts in river macroinvertebrate assemblages.

Molecular ecology resources·2023
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023
Same author

Alpha1-antitrypsin deficiency in Greece: Focus on rare variants.

Pulmonology·2023
Same author

Early Pseudomonas aeruginosa predicts poorer pulmonary function in preschool children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same journal

Mediastinal amyloidosis mimicking advanced lung cancer.

Thorax·2026
Same journal

Comparative performance of endobronchial ultrasound-guided sampling techniques in patients with mediastinal lesions: a network meta-analysis.

Thorax·2026
Same journal

Vitamin A and D impact on lung function: differential or common effects across the lifespan?

Thorax·2026
Same journal

The impact of vitamins A and D on lung function and regulatory epigenetics in adult and childhood asthma.

Thorax·2026
Same journal

Radiological factors associated with the recurrence of <i>Mycobacterium avium complex</i> pulmonary disease: a multicentre retrospective cohort study.

Thorax·2026
Same journal

Daughter vesicles in primary diaphragmatic hydatid cyst.

Thorax·2026
See all related articles

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacy

Background:

  • High-dose corticosteroid use in asthmatic children necessitates careful evaluation.
  • Challenges exist in managing treatment adherence and financial support claims.

Purpose of the Study:

  • To assess the necessity of high-dose corticosteroids in pediatric asthma.
  • To identify optimal strategies for improving treatment adherence.
  • To evaluate specialist assessment components and new treatments for difficult asthma.

Main Methods:

  • Comprehensive assessment of pediatric asthma patients on high-dose corticosteroids.
  • Investigation into factors influencing treatment adherence.
  • Prospective evaluation of specialist assessment benefits.
  • Multicenter collaboration for treatment research.

Related Experiment Videos

Main Results:

  • High-dose corticosteroid use in children with asthma requires careful justification.
  • Addressing poor treatment adherence and financial support claims is crucial.
  • Further research is needed to optimize specialist assessments and treatments.

Conclusions:

  • Thorough assessment is vital for children with asthma on high-dose corticosteroids.
  • Improved strategies for treatment adherence and financial support are necessary.
  • Multicenter studies are essential for advancing phenotype-specific and novel therapies for difficult asthma.